ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Isoalantolactone Induces Cell Cycle Arrest, Apoptosis and Autophagy in Colorectal Cancer Cells

Li, Junkui; Zhu, Peili; Chen, Yifei; Zhang, Shiqing; Zhang, Zhu; Zhang, Zhang; Wang, Ying; Jiang, Xiaoli; Lin, Kaili; Wu, Wei; Mo, Zhixian*; Sze, Stephen Cho Wing*; Yung, Ken Kin Lam*广州医学院; 南方医科大学
Frontiers in Pharmacology2022-5-12DOI: 10.3389/fphar.2022.903599
8被引23阅读
引用收藏
分享

摘要

Colorectal cancer (CRC) is an aggressive cancer. Isoalantolactone (IATL) has been reported to exert cytotoxicity against various cancer cells, but not CRC. In this study, we explored the anti-CRC effects and mechanism of action of IATL in vitro and in vivo. Our results demonstrated that IATL inhibited proliferation by inducing G0/G1 phase cell cycle arrest, apoptosis and autophagy in CRC cells. Repression of autophagy with autophagy inhibitors chloroquine (CQ) and Bafilomycin A1 (Baf-A1) enhanced the anti-CRC effects of IATL, suggesting that IATL induces cytoprotective autophagy in CRC cells. Mechanistic studies revealed that IATL lowered protein levels of phospho-AKT (Ser473), phospho-mTOR (Ser2448), phospho-70S6K (Thr421/Ser424) in CRC cells. Inhibition of AKT and mTOR activities using LY294002 and rapamycin, respectively, potentiated the inductive effects of IATL on autophagy and cell death. In vivo studies showed that IATL suppressed HCT116 tumor growth without affecting the body weight of mice. In consistent with the in vitro results, IATL lowered protein levels of Bcl-2, Bcl-XL, phospho-AKT (Ser473), phospho-mTOR (Ser2448), and phsopho-70S6K (Thr421/Ser424), whereas upregulated protein levels of cleaved-PARP and LC3B-II in HCT116 tumors. Collectively, our results demonstrated that in addition to inhibiting proliferation, inducing G0/G1-phase cell cycle arrest and apoptosis, IATL initiates cytoprotective autophagy in CRC cells by inhibiting the AKT/mTOR signaling pathway. These findings provide an experimental basis for the evaluation of IATL as a novel medication for CRC treatment.

学科与关键词

关键词
isoalantolactonecolorectal cancercell cycle arrestapoptosisautophagyAKTmTOR signaling
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Frontiers in Pharmacology
发表日期
2022-05-12
卷期
第 13 卷
页码
903599
DOI
10.3389/fphar.2022.903599
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81903868]; Natural Science Foundation of Guangdong Province [2021A1515012093, 2021A1515010657]; Scientific research project of Traditional Chinese medicine Bureau of Guangdong Province [20222138]; Guangdong Basic and Applied Basic Research Foundation [2019A1515011497]

作者

  • L

    Li, Junkui (第一作者)

    hkbu · hong kong baptist univ

  • Z

    Zhu, Peili

    hkbu · hong kong baptist univ

查看全部 13 位作者收起作者
  • C

    Chen, Yifei

    southern med univ · guilin med univ

  • Z

    Zhang, Shiqing

    hkust · hkbu

  • Z

    Zhang, Zhu

  • Z

    Zhang, Zhang

  • W

    Wang, Ying

    hkbu · hong kong baptist univ

  • J

    Jiang, Xiaoli

    hkbu · hong kong baptist univ

  • L

    Lin, Kaili

    guangzhou med univ · hkbu

  • W

    Wu, Wei

    guilin med univ

  • M

    Mo, Zhixian (通讯)

    southern med univ

  • S

    Sze, Stephen Cho Wing (通讯)

    hkbu · hong kong baptist univ

  • Y

    Yung, Ken Kin Lam (通讯)

    hkbu · hong kong baptist univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417